advanced search

INJECTION

AN INCLUSIVE APPROACH TO THE DEVELOPMENT OF PLATFORM MEDICAL DEVICES
PREFILLED SYRINGES
Finola Austin
Owen Mumford
AN INCLUSIVE APPROACH TO THE DEVELOPMENT OF PLATFORM MEDICAL DEVICES
Finola Austin discusses the difficulties presented by designing a user testing programme for platform devices when the target patient population is as yet unknown, and presents the testing framework based on seven user groups that Owen Mumford uses to meet this challenge.
BD HYLOK™ – GLASS PREFILLABLE SYRINGE FOR IV APPLICATIONS
PREFILLED SYRINGES
Sophie Trémeau
BD (Becton Dickinson & Company)
BD HYLOK™ – GLASS PREFILLABLE SYRINGE FOR IV APPLICATIONS
Sophie Trémeau, Maxime Nicolas and Myriam Leszczynski discuss BD Hylok™, a prefillable glass syringe for intravenous applications, including the rigorous testing BD Hylok™ has undergone and the regulatory support BD is able to provide to its pharmaceutical partners.
INNOVATING IN THE VISCOSITY DESIGN SPACE: A NEW 2.25 ML AUTOINJECTOR PLATFORM
INJECTION
Karima Yadi
BD (Becton Dickinson & Company)
INNOVATING IN THE VISCOSITY DESIGN SPACE: A NEW 2.25 ML AUTOINJECTOR PLATFORM
Karima Yadi and Lionel Maritan discuss BD’s response to the need for an autoinjector platform that reconciles the demands of biologics with safety, reliability and ease of use during self-injection: the Intevia™ 2.25 mL disposable autoinjector.
HOW TO KEEP THE GRANDFATHER DILEMMA FROM INTERRUPTING DRUG REDEVELOPMENT
INJECTION
Chris Rojewski
Pfizer CentreOne
HOW TO KEEP THE GRANDFATHER DILEMMA FROM INTERRUPTING DRUG REDEVELOPMENT
Chris Rojewski provides programme insights into approval pathways for the redevelopment of pharmaceutical compounds.
INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING
SUSTAINABILITY
Jiae Kim
Roquette
INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING
Jiae Kim introduces isosorbide, a plant starch-derived diol made from renewable feedstock that has wide ranging applications across polymer materials for a variety of industries.
CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION
EXPERT VIEW
George I’ons
CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION
George I’ons discusses the challenges developing connected devices presents to key market stakeholders when it comes to successful rollout and implementation. Additionally, he considers the perspectives of these market players, as well as the patients themselves, with respect to how connected drug delivery devices can help them to better achieve their desired outcomes.
MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE
CONNECTIVITY
Mr Michael Kiely
Jabil Healthcare
MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE
Michael Kiely, Laura Marsden, Peter Stringer, and David Boyle discuss the design challenges at the electromechanical interface and encourage manufacturers to adopt a standardised approach for connecting medical devices to the cloud.
MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE
CONNECTIVITY
Arnaud Guillet
Biocorp
MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE
Arnaud Guillet reviews the Mallya connected device platform, from the origins of the project to the current success in diabetes and deployment in other fields, and introduces the promising next-generation Mallya.
THE COVID-19 CATALYST: HOW A GLOBAL PANDEMIC IS ACCELERATING THE NEED FOR DIGITAL HEALTH
CONNECTIVITY
Marcus Bates
Aptar Pharma
THE COVID-19 CATALYST: HOW A GLOBAL PANDEMIC IS ACCELERATING THE NEED FOR DIGITAL HEALTH
Marcus Bates discusses the positive impact covid-19 has had on the digital health industry, including the acceleration and development of remote patient services.
D-FLEX<sup>®</sup> ECOSYSTEM – FROM DATA TO VALUE
CONNECTIVITY
Dr Fred Metzmann
Haselmeier
D-FLEX® ECOSYSTEM – FROM DATA TO VALUE
Fred Metzmann and Frank Leipold discuss the benefits of connected medical devices in clinical trials and describe the advantages of Haselmeier's D-Flex® Ecosystem for improving adherence and reducing the dropout rate in clinical trials.
THE NEW EMERGING NEEDS DRIVING AUTOINJECTOR DEVELOPMENT
INJECTION
Dr Iain Simpson
Phillips Medisize
THE NEW EMERGING NEEDS DRIVING AUTOINJECTOR DEVELOPMENT
Iain Simpson discusses the emerging needs to be considered when bringing new autoinjector drug-device combinations to market.
MEASURING & MANAGING MEDICATION ADHERENCE FROM CLINICAL TRIALS TO ROUTINE CARE: INJAY MEMS AS<sup>®</sup>
CONNECTIVITY
Arnaud Guillet
Biocorp
MEASURING & MANAGING MEDICATION ADHERENCE FROM CLINICAL TRIALS TO ROUTINE CARE: INJAY MEMS AS®
Arnaud Guillet and Bernard Vrijens discuss the issue of medication non-adherence in both clinical trials and commercialised drug products, and how Biocorp’s Injay connected prefilled syringe solution combined with Aardex’s MEMS Adherence Software provides a solution.
THE “CUSTOMISABLE PLATFORM” PARADOX
INDUSTRIALISATION
Lyndon Wild
SHL Medical
THE “CUSTOMISABLE PLATFORM” PARADOX
Lyndon Wild and Gene Rhode Fuensalida Pantig present a systematic analysis of the customisable platform architecture found in the Molly® autoinjector technology.
TRAINING DEVICES & PATIENT EDUCATION PLAY A CRUCIAL ROLE IN THE SELF-INJECTION DRUG DELIVERY MARKET
PREFILLED SYRINGES
Joe Reynolds
Noble
TRAINING DEVICES & PATIENT EDUCATION PLAY A CRUCIAL ROLE IN THE SELF-INJECTION DRUG DELIVERY MARKET
Joe Reynolds discusses the role training devices and patient education play with regard to self-injection therapies.
LEVERAGING INTEGRATION THROUGHOUT A DRUG DELIVERY SYSTEM PROJECT
INDUSTRIALISATION
Steven Kaufman
Stevanato Group
LEVERAGING INTEGRATION THROUGHOUT A DRUG DELIVERY SYSTEM PROJECT
Steven Kaufman and Adam Stops describe how an integrated offering can help customers at each phase of a drug delivery system project.
GERRESHEIMER INCLUDES STEVANATO GROUP INTEGRATED TWIST-OFF CLOSURE SYSTEM FOR GX<sup>®</sup> RTF SYRINGES
PREFILLED SYRINGES
Mr Maximilian Vogl
Gerresheimer
GERRESHEIMER INCLUDES STEVANATO GROUP INTEGRATED TWIST-OFF CLOSURE SYSTEM FOR GX® RTF SYRINGES
Maximilian Vogl reveals the latest user-friendly addition to its Gx RTF Luer lock syringes using Stevanto Group’s integrated twist-off closure technology.
VERIFYING THE CONTAINER CLOSURE INTEGRITY OF CUSTOM PRIMARY PACKAGING
PREFILLED SYRINGES
Dr Alex Vasiev
SMC Ltd
VERIFYING THE CONTAINER CLOSURE INTEGRITY OF CUSTOM PRIMARY PACKAGING
Alex Vasiev, Connor Everett and Steven Hay explore the challenges of verifying the container closure integrity of custom primary packaging.
UNISAFE<sup>®</sup> 2.25: SEAMLESSLY TRANSITIONING TO NEW-GENERATION BIOLOGICS
PREFILLED SYRINGES
George I’ons
Owen Mumford
UNISAFE® 2.25: SEAMLESSLY TRANSITIONING TO NEW-GENERATION BIOLOGICS
George I’ons discusses the benefits of subcutaneously administering new drug formulations, and the factors that manufacturers need to consider when designing delivery devices.
POLYMER SYRINGE CONSIDERATIONS FOR DRUG APPLICATIONS AND ADMINISTRATION
PREFILLED SYRINGES
Tibor Hlobik
West Pharmaceutical Services
POLYMER SYRINGE CONSIDERATIONS FOR DRUG APPLICATIONS AND ADMINISTRATION
Tibor Hlobik compares cyclo-olefin polymers and copolymers with glass as the material of choice for prefilled syringes, in particular discussing the benefits of polymers when it comes to biologic drug products and prefilled syringes for use in autoinjectors.
OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
PREFILLED SYRINGES
Shota Arakawa
Mitsubishi Gas Chemical
OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
Shota Arakawa and Tomohiro Suzuki discuss MGC’s OXYCAPT™ vial and syringe primary containers, including the OXYCAPT™ material and product offering, as well as where MGC sees OXYCAPT™ fitting into the modern pharmaceutical market.
VERIFICATION OF INJECTABLES IN TRANSPORT AND STORAGE
PREFILLED SYRINGES
Mark Turner
Medical Engineering Technologies
VERIFICATION OF INJECTABLES IN TRANSPORT AND STORAGE
Mark Turner discusses the regulations and requirements around testing combination products for their stability in storage over their shelf-life and during transport.
ENHANCING PROTEIN PRESERVATION DURING BIOLOGICAL DRUG PREPARATION AND DELIVERY
INJECTION
Adrien Bouillet
Eveon
ENHANCING PROTEIN PRESERVATION DURING BIOLOGICAL DRUG PREPARATION AND DELIVERY
Adrien Bouillet, Loïc Girois and Marianne Weidenhaupt, discuss the results of work carried out in joint efforts by EVEON and LMGP in the field of protein adsorption and aggregation, and how the results of this work have led to improvements in the design of EVEON’s proprietary micropump.
THE CHANGING FACE OF AUTOINJECTOR TECHNOLOGY
INJECTION
Bespak
THE CHANGING FACE OF AUTOINJECTOR TECHNOLOGY
Reenal Gandhi discusses the advantages offered by liquefied gas as a power source for autoinjectors compared with conventional spring-based systems, as well as covering the benefits of using a platform model for drug delivery device development.
THE IMPORTANCE OF A GREAT DEVELOPMENT EXPERIENCE TO ACHIEVE A GREAT MEDICAL DEVICE
PREFILLED SYRINGES
William Fortina
THE IMPORTANCE OF A GREAT DEVELOPMENT EXPERIENCE TO ACHIEVE A GREAT MEDICAL DEVICE
William Fortina considers the importance of the medical device development experience in the healthcare context and discusses the factors that make for a superior development process.
Top